# Distinct Response of CD4+CD25+Foxp3+ and IL-10-secreting Type I T Regulatory Cells to Cluster Specific Immunotherapy in Allergic Rhinitis Children

> **NCT01291381** · NA · COMPLETED · sponsor: **Beijing Tongren Hospital** · enrollment: 50 (actual)

## Conditions studied

- Allergic Rhinitis
- Effects of Immunotherapy

## Interventions

- **DRUG:** Dermatophagoides pteronyssinus
- **DRUG:** Pharmacotherapy

## Key facts

- **NCT ID:** NCT01291381
- **Lead sponsor:** Beijing Tongren Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2010-02
- **Final completion:** 2010-10
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2011-02-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01291381

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01291381, "Distinct Response of CD4+CD25+Foxp3+ and IL-10-secreting Type I T Regulatory Cells to Cluster Specific Immunotherapy in Allergic Rhinitis Children". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01291381. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*